In November 2024, the following ongoing mini-HTA assessments for cardiovascular, diagnostic imaging, e-health, gastrointestinal, in-vitro diagnostics, interventional radiology, men’s health, pulmonary and airways, robotic surgery, and some other fields are evaluated as a part of a framework for the managed introduction of innovations "New Methods" in Norway.

In November 2024, NICE introduced CHEERS-AI - a new reporting standard for health economic evaluations of AI technologies. This will help healthcare decision-makers understand the value of AI-enabled treatments, allowing patients to access the most promising ones faster.

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients to better understand the potential scope of our support. From the week of November 18th, we are planning to work on 14 projects. Review the complete list of planned activities in this post.

In October 2024, the Agreements on new pathologies and procedures for the care of which it is necessary to designate Benchmark centers, departments, and units of the National Health System (CSURs) were approved in the cardiovascular, endoscopy, gastrointestinal, nephrology, and urology, obstetrics and gynecology, surgical procedures, neuromodulation, and peripheral vascular fields. In addition, several CSURs were designated or redesignated for previously approved pathologies and procedures.

On October 31, 2024, the Swiss Federal Statistics Office (UFS) released the systematic version of the procedure code (CHOP) nomenclature for 2025. The nomenclature is now available in German, Italian, and French languages and will come into force on January 1, 2025. Multiple new procedure codes were introduced in various fields, including endoscopy, extracorporeal treatments, in-vitro diagnostics, interventional radiology, obstetrics and gynecology, orthopedics, and radiotherapy.

In October 2024, the Ministry of Health, Welfare, and Sport decided to discontinue the "Subsidy scheme for promising care," which was implemented in 2019 to support the development of missing clinical and economic evidence for promising care that otherwise cannot be covered within basic health insurance. There are 28 ongoing projects, and some new projects will be awarded the subsidy in the 2025 round.

On October 24, 2024, the BfArM (Federal Institute for Drugs and Medical Devices) published the final version of the 2025 OPS procedure coding classification. The OPS, together with the ICD-10-GM (International Statistical Classification of Diseases and Related Health Problems, 10th revision, German Modification), forms the basis for the reimbursement systems in outpatient and inpatient care in Germany. Multiple new procedure codes were introduced in several fields, including cardiovascular, endoscopic, peripheral vascular, and robotic surgery.

In October 2024, the National Institute for Health and Care Research (NIHR) in England released seven Med Tech-related assessments in its HTA Journal, which concerned the Genedrive kit, timing of stoma closure in neonates, interventions in perceptual disorders after stroke, revascularisation strategy for chronic limb ischemia, MRI software and cognitive fusion biopsies in prostate cancer, transperineal prostate biopsy devices, and ultraviolet therapy in severe eczema. HTA Journal publishes research reports on the effectiveness, costs, and broader impact of health technologies for those who use, manage, and provide care in the NHS and informs NICE guidance.

In November 2024, the Danish Government presented a new Strategy for Life Science towards 2030. The Strategy will strengthen the role of innovative health solutions in relation to freeing up labor and ensuring a sustainable healthcare system. The Vision is that Denmark must be a leading life science nation in Europe to benefit patients, the Danish healthcare system, and the Danish economy.

The French National Authority for Health (HAS) released new recommendations about add-on reimbursement of medical devices and medical aids from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in October 2024. Ten recommendations were published concerning the registration or modification of registration conditions/extension of indications for the medical devices in the List of Reimbursable Products and Services (LPPR). Opinions concern cardiovascular, peripheral vascular, neurovascular, and interventional radiology devices, as well as medical aids.

In October 2024, the National Institute for Health and Care Excellence (NICE) published two new Diagnostics Guidance concerning heart failure algorithms for remote monitoring in people with cardiac implantable electronic devices and digital technologies for assessing attention deficit hyperactivity disorder.

The MTRC team, including Director Oleg Borisenko and Reimbursement Leads, will be attending the ISPOR meeting in Barcelona on 18-20 November 2024. Visit us at booth #829 to discuss your needs in European market access, health economics, and evidence synthesis for medical technologies.